Page last updated: 2024-09-05

dapivirine and r-82913

dapivirine has been researched along with r-82913 in 2 studies

Compound Research Comparison

Studies
(dapivirine)
Trials
(dapivirine)
Recent Studies (post-2010)
(dapivirine)
Studies
(r-82913)
Trials
(r-82913)
Recent Studies (post-2010) (r-82913)
196641606510

Protein Interaction Comparison

ProteinTaxonomydapivirine (IC50)r-82913 (IC50)
Chain A, Reverse TranscriptaseHuman immunodeficiency virus type 1 (CLONE 12)0.033
Chain A, Reverse TranscriptaseHuman immunodeficiency virus 10.033
Chain B, Reverse TranscriptaseHuman immunodeficiency virus 10.033
Gag-Pol polyproteinHIV-1 M:B_HXB2R2.0078
Reverse transcriptase/RNaseH Human immunodeficiency virus 10.45
Protease Human immunodeficiency virus 13.8155

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Corte, BL1
De Clercq, E; Li, Z; Liu, X; Pannecouque, C; Zhan, P1

Reviews

2 review(s) available for dapivirine and r-82913

ArticleYear
From 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk](1,4)benzodiazepin-2(1H)-one (TIBO) to etravirine (TMC125): fifteen years of research on non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Journal of medicinal chemistry, 2005, Mar-24, Volume: 48, Issue:6

    Topics: Anti-HIV Agents; Benzodiazepines; Drug Design; Drug Resistance, Viral; HIV Reverse Transcriptase; Imidazoles; Nitriles; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors

2005
Design strategies of novel NNRTIs to overcome drug resistance.
    Current medicinal chemistry, 2009, Volume: 16, Issue:29

    Topics: Anti-HIV Agents; Benzodiazepines; Drug Design; Drug Resistance, Viral; Humans; Imidazoles; Models, Biological; Molecular Structure; Pyrimidines; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase

2009